- Home
- HNRG vs JANX Comparison
HNRG vs JANX Comparison
Compare HNRG & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HNRG | JANX |
|---|---|---|
| Founded | 1949 | 2017 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Coal Mining | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 826.2M | 984.3M |
| IPO Year | 1995 | 2021 |
Fundamental Metrics
Financial Performance| Metric | HNRG | JANX |
|---|---|---|
| Price | $14.52 | $14.77 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 13 |
| Target Price | $25.38 | ★ $47.00 |
| AVG Volume (30 Days) | 681.6K | ★ 940.4K |
| Earning Date | 05-06-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 116.78 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $469,466,000.00 | $10,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.12 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 16.09 | N/A |
| 52 Week Low | $14.65 | $12.12 |
| 52 Week High | $24.70 | $35.34 |
Technical Indicators
Market Signals| Indicator | HNRG | JANX |
|---|---|---|
| Relative Strength Index (RSI) | 35.94 | 44.19 |
| Support Level | N/A | $13.13 |
| Resistance Level | $20.08 | $15.49 |
| Average True Range (ATR) | 0.75 | 0.63 |
| MACD | -0.13 | -0.17 |
| Stochastic Oscillator | 6.60 | 16.27 |
Price Performance
Historical ComparisonAbout HNRG Hallador Energy Company
Hallador Energy Co is a vertically integrated, independent power producer (IPP) and fuel company with operations in Indiana. The Company operates across multiple stages of the energy value chain, from accredited capacity and energy to coal. The Company's electric operations are located within the Midcontinent Independent System Operator's (MISO) footprint. The company's business is organized based on the services and products it provide in two segments: (i) Electric Operations and (ii) Coal Operations.
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. The proprietary technology of the company has enabled the development of distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr), Tumor Activated Immunomodulators (TRACIr), and Adaptive Immune Response Modulator (ARM) platforms. The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.